Stocks · Healthcare · Medical - Instruments & Supplies
Teleflex Incorporated TFX
$124.12 -1.58% Close, Oct 2, 2026 · NYSE · Market cap $5.49B
High qualityLow risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-23.29, down 648.0% year over year.
- Operating margin narrowed to 3.3% from 10.5% a year earlier.
- Revenue over the last four quarters was $2.60B, down 14.5% from a year earlier, slowing from -6.6% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 18%
- EPS growth (TTM, YoY)Bottom 5%
- FCF growth (TTM, YoY)Bottom 38%
- Revenue growth, 3-year CAGRBottom 10%
- Revenue growth accelerationBottom 20%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 30%
- Gross marginBottom 38%
- Operating marginTop 37%
- Accruals (lower is better)Top 12%
- Interest coverTop 41%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 34%
- Free-cash-flow yieldTop 12%
- EBITDA / enterprise valueTop 46%
- Sales / enterprise valueTop 40%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 44%
- 6-month returnBottom 48%
- 1-year return vs S&P 500Bottom 43%
- Distance from 52-week highTop 22%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 49%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 20%
- Upside to consensus price targetBottom 30%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 6%
- Maximum drawdown, 3 yearsTop 36%
- Beta vs S&P 500 (lower is better)Top 21%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -6.6% | -14.5% | ↓ |
| EPS growth (YoY) | -819.2% | -648.0% | ↑ |
| Gross margin | 55.6% | 53.8% | ↓ |
| Operating margin | 10.5% | 3.3% | ↓ |
| FCF margin | 13.0% | 15.0% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -14.5% | -6.6% | ↓ | Bottom 18% |
| EPS growth (TTM, YoY) | -648.0% | -819.2% | ↑ | Bottom 5% |
| Gross margin | 53.8% | 55.6% | ↓ | Bottom 38% |
| Operating margin | 3.3% | 10.5% | ↓ | Top 37% |
| Net margin | -39.6% | 6.3% | ↓ | — |
| Free-cash-flow margin | 15.0% | 13.0% | ↑ | — |
| Return on invested capital | 1.3% | — | Top 30% | |
| Revenue growth, 3-year CAGR | -10.6% | — | Bottom 10% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -21.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -14.5 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 0.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 1.09%
- Net buyback yield (TTM)
- 4.55%
- Shareholder yield
- 5.64%
- Share count change, 1 year
- -4.9%
- Share count change, 3-year CAGR
- -2.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +3.2%
- Average 2-day reaction, last 8
- -4.7%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $155.25
- Target vs current price
- +25.1%
- Analysts with a rating
- 29
- Share rating Buy or Strong Buy
- 55%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +37.5% | +1.5% | -0.3% | +3.1% | — |
| May 7, 2026 | +14.9% | +6.9% | +5.5% | +7.2% | +13.4% |
| Feb 26, 2026 | -48.3% | +6.4% | +6.5% | -3.3% | +17.9% |
| Nov 6, 2025 | +8.6% | -13.0% | -10.6% | -4.7% | -17.9% |
| Jul 31, 2025 | +11.0% | +4.9% | -1.6% | +13.7% | +16.2% |
| May 1, 2025 | +1.0% | -8.2% | -10.9% | -10.6% | -15.7% |
| Feb 27, 2025 | +0.8% | -21.7% | -24.5% | -21.1% | -31.9% |
| Oct 31, 2024 | +3.3% | -14.5% | -14.2% | -18.4% | -23.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $1.76 | $1.28 | +37.5% | $570.3M |
| May 7, 2026 | $1.39 | $1.21 | +14.9% | $548.3M |
| Feb 26, 2026 | $1.93 | $3.73 | -48.3% | $569.0M |
| Nov 6, 2025 | $3.67 | $3.38 | +8.6% | $913.0M |
| Jul 31, 2025 | $3.73 | $3.36 | +11.0% | $780.9M |
| May 1, 2025 | $2.91 | $2.88 | +1.0% | $700.7M |
| Feb 27, 2025 | $3.89 | $3.86 | +0.8% | $795.4M |
| Oct 31, 2024 | $3.49 | $3.38 | +3.3% | $764.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 17.2× | — | — | — |
| EV / Sales | 3.10× | — | — | Top 40% |
| Free-cash-flow yield | 7.11% | — | — | Top 12% |
| Earnings yield | -18.76% | — | — | Bottom 34% |
P/E over the past five years
Range 22.8× – 93.5× since Jun 27, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +0.2%
- Earnings per share growth (TTM)
- -648.0%
- Change in P/E multiple
- -33.9%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 5
- 50-day average slope (20 days)
- -1.4%
- 200-day average slope (20 days)
- +0.9%
- Distance from 50-day average
- -6.8%
- Distance from 200-day average
- +0.1%
- RSI (14)
- 39.7
- Relative volume
- 0.77×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 27.6%
- Volatility vs own 5-year history
- 19th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.60
- Correlation with S&P 500
- 0.24
- Current drawdown from 1-year high
- -12.6%
- Maximum drawdown, 3 years
- -60.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 28, 2021 | Jan 20, 2026 | -77.4% | 1187 days | Not yet recovered |
| Oct 22, 2020 | Oct 30, 2020 | -13.6% | 6 days | 7 days (Nov 10, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $5.49B
- EPS, diluted (TTM)
- -$23.29
- Revenue (TTM)
- $2.60B
- Dividend yield
- 1.10%
- 52-week range
- $100.18 – $145.00
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.81B | $2.79B | $2.97B | $3.05B | $1.99B |
| Gross profit | $1.55B | $1.53B | $1.65B | $1.70B | $1.12B |
| Operating income | $628.1M | $499.7M | $506.3M | $151.0M | $255.8M |
| Net income | $485.4M | $363.1M | $356.3M | $69.7M | -$905.6M |
| EPS (diluted) | $10.23 | $7.68 | $7.53 | $1.48 | -$20.25 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $764.4M | $795.4M | $700.7M | $780.9M | $913.0M | $569.0M | $548.3M | $570.3M |
| Net income | $111.0M | -$136.7M | $95.0M | $122.6M | -$408.9M | -$714.3M | -$8.2M | $102.0M |
| EPS (diluted) | $2.36 | -$2.95 | $2.07 | $2.77 | -$9.24 | -$16.15 | -$0.18 | $2.28 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $651.4M | $342.1M | $510.6M | $635.7M | $340.7M |
| Capital expenditure | -$71.6M | -$79.2M | -$91.4M | -$126.4M | -$95.2M |
| Free cash flow | $579.8M | $263.0M | $419.2M | $509.3M | $245.4M |
| Dividends paid | -$63.6M | -$63.8M | -$63.9M | -$63.5M | -$60.3M |
| Net share buybacks | $11.1M | $0 | $0 | -$200.0M | -$300.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $300.2M
- Total assets
- $6.79B
- Total liabilities
- $3.88B
- Total debt
- $2.87B
- Net debt
- $2.57B
- Shareholders’ equity
- $2.90B
As of Jun 30, 2026 (filed Aug 6, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 14, 2026 | $0.34 | Sep 30, 2026 |
| May 22, 2026 | $0.34 | Jun 30, 2026 |
| Mar 6, 2026 | $0.34 | Mar 31, 2026 |
| Nov 14, 2025 | $0.34 | Dec 15, 2025 |
| Aug 15, 2025 | $0.34 | Sep 15, 2025 |
| May 20, 2025 | $0.34 | Jun 16, 2025 |
| Mar 7, 2025 | $0.34 | Mar 17, 2025 |
| Nov 15, 2024 | $0.34 | Dec 16, 2024 |
Short interest
- Shares sold short
- 4,002,853
- Days to cover
- 6.10
- Change vs previous report
- -0.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 17, 1997
- 2-for-1
- Jun 17, 1991
- 3-for-2
- Jun 17, 1986
- 2-for-1
- Sep 16, 1981
- 3-for-2
- Dec 16, 1980
- 2-for-1